Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2022 Filed Feb 25, 2022 02:22 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $32.20 | $0.00 |
DisclosureSEC source: 0001104659-22-026873 · tm227622-11_4seq1.xml · derivative · entry 2 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2032-02-22 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 22:15 UTC Amendment |
Rubin JonathanSVP, Chief Medical Officer
|
GrantRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-027392 · tm227764-2_4aseq1.xml · derivative · entry 2 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023. F3 · derivative.expiration_date: The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 22:15 UTC Amendment |
Rubin JonathanSVP, Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $32.20 | $0.00 |
DisclosureSEC source: 0001104659-22-027392 · tm227764-2_4aseq1.xml · derivative · entry 1 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-02-22 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 22:15 UTC Amendment |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
GrantRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-027394 · tm227764-3_4aseq1.xml · derivative · entry 3 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F2 · derivative.exercise_price: The option vests in four equal annual installments beginning on February 22, 2023. F4 · derivative.exercise_date: The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023. F4 · derivative.expiration_date: The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 22:15 UTC Amendment |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $32.20 | $0.00 |
DisclosureSEC source: 0001104659-22-027394 · tm227764-3_4aseq1.xml · derivative · entry 2 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2032-02-22 F3 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 22:14 UTC Amendment |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantRestricted Stock Units · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-027391 · tm227764-1_4aseq1.xml · derivative · entry 2 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023. F3 · derivative.expiration_date: The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 22:14 UTC Amendment |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $32.20 | $0.00 |
DisclosureSEC source: 0001104659-22-027391 · tm227764-1_4aseq1.xml · derivative · entry 1 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-02-22 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 22:17 UTC Amendment |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
GrantRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-027398 · tm227764-5_4aseq1.xml · derivative · entry 3 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023. F4 · derivative.expiration_date: The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 22:17 UTC Amendment |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $32.20 | $0.00 |
DisclosureSEC source: 0001104659-22-027398 · tm227764-5_4aseq1.xml · derivative · entry 2 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2032-02-22 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 22:17 UTC Amendment |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-027397 · tm227764-4_4aseq1.xml · derivative · entry 3 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023. F4 · derivative.expiration_date: The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 22:17 UTC Amendment |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $32.20 | $0.00 |
DisclosureSEC source: 0001104659-22-027397 · tm227764-4_4aseq1.xml · derivative · entry 2 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2032-02-22 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 16:20 UTC |
NEWHALL CHARLES W IIIDirector
|
Disposition to issuerRestricted Stock Units · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-026109 · tm227492-5_4seq.xml · derivative · entry 2 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022. F2 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 16:20 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantCommon Stock | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-026109 · tm227492-5_4seq.xml · nonDerivative · entry 1 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,731 Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 16:16 UTC |
Hudson Frederick M.Director
|
Disposition to issuerRestricted Stock Units · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-026100 · tm227492d2_4seq1.xml · derivative · entry 2 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022. F2 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 16:16 UTC |
Hudson Frederick M.Director
|
GrantCommon Stock | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-026100 · tm227492d2_4seq1.xml · nonDerivative · entry 1 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,263 Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 16:15 UTC |
SIEBERT JOHN MDirector
|
Disposition to issuerRestricted Stock Units · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-026096 · tm227492-1_4seq1.xml · derivative · entry 2 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022. F2 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 16:15 UTC |
SIEBERT JOHN MDirector
|
GrantCommon Stock | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-026096 · tm227492-1_4seq1.xml · nonDerivative · entry 1 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,175 Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:17 UTC |
GEMAYEL GEORGESDirector
|
Disposition to issuerRestricted Stock Units · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-026103 · tm227492d3_4seq1.xml · derivative · entry 2 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022. F2 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:17 UTC |
GEMAYEL GEORGESDirector
|
GrantCommon Stock | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-026103 · tm227492d3_4seq1.xml · nonDerivative · entry 1 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,433 Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:19 UTC |
Barlow CarroleeDirector
|
Disposition to issuerRestricted Stock Units · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-026108 · tm227492-4_4seq1.xml · derivative · entry 2 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022. F2 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:19 UTC |
Barlow CarroleeDirector
|
GrantCommon Stock | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-026108 · tm227492-4_4seq1.xml · nonDerivative · entry 1 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,433 Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 21:17 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 85,000 | $0.00 Strike: $25.09 | $0.00 |
DisclosureSEC source: 0001104659-21-109013 · tm2125812-2_4seq1.xml · derivative · entry 1 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2031-08-23 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on August 23, 2021. Read SEC document |
| August 11, 2021 Filed Aug 12, 2021 16:32 UTC |
SIEBERT JOHN MDirector
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $12.98 | $0.00 |
DisclosureSEC source: 0001104659-21-104206 · tm2124999-1_4seq1.xml · derivative · entry 2 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2021 Filed Aug 12, 2021 16:32 UTC |
SIEBERT JOHN MDirector
|
Exercise / conversionCommon Stock | 15,000 | $12.98 | $194,700.00 |
DisclosureSEC source: 0001104659-21-104206 · tm2124999-1_4seq1.xml · nonDerivative · entry 1 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2021 Filed Jul 30, 2021 20:32 UTC |
Khattar Jack A.Director · President, CEO
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-098285 · tm2123766-1_4seq1.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,466 Read SEC document |
| July 30, 2021 Filed Jan 13, 2023 22:00 UTC Amendment |
Khattar Jack A.Director · President, CEO
|
GrantPerformance Share Unit · Derivative | 40,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-003860 · tm233200-1_4aseq1.xml · derivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-02-19 F2 · derivative.exercise_date: On February 19, 2021, the Reporting Person was awarded Performance Shares Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period. Read SEC document |
| April 14, 2021 Filed Apr 15, 2021 00:24 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,125 | $0.00 Strike: $12.98 | $0.00 |
DisclosureSEC source: 0001104659-21-050369 · tm2113039-1_4seq1.xml · derivative · entry 6 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 3,125 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted March 11, 2021. F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 1, 2017. Read SEC document |
| April 14, 2021 Filed Apr 15, 2021 00:24 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
SaleCommon Stock | 3,125 | $31.98 | $99,937.50 |
DisclosureSEC source: 0001104659-21-050369 · tm2113039-1_4seq1.xml · nonDerivative · entry 4 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,326 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted March 11, 2021. Read SEC document |
| April 14, 2021 Filed Apr 15, 2021 00:24 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Exercise / conversionCommon Stock | 3,125 | $12.98 | $40,562.50 |
DisclosureSEC source: 0001104659-21-050369 · tm2113039-1_4seq1.xml · nonDerivative · entry 3 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted March 11, 2021. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 00:24 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,125 | $0.00 Strike: $12.98 | $0.00 |
DisclosureSEC source: 0001104659-21-050369 · tm2113039-1_4seq1.xml · derivative · entry 5 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 3,125 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted March 11, 2021. F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 1, 2017. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 00:24 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
SaleCommon Stock | 3,125 | $29.98 | $93,701.88 |
DisclosureSEC source: 0001104659-21-050369 · tm2113039-1_4seq1.xml · nonDerivative · entry 2 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,326 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted March 11, 2021. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 00:24 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Exercise / conversionCommon Stock | 3,125 | $12.98 | $40,562.50 |
DisclosureSEC source: 0001104659-21-050369 · tm2113039-1_4seq1.xml · nonDerivative · entry 1 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted March 11, 2021. Read SEC document |
| March 26, 2021 Filed Mar 30, 2021 22:23 UTC |
Khattar Jack A.Director · President, CEO
|
OtherCommon Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-044088 · tm2111424-1_4seq1.xml · nonDerivative · entry 2 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the KBT Trust Disclosed balance after: 1,058,450 F1 · price: The Reporting Person is filing this Form 4 to reflect the fact that 10,000 shares were transferred from the KBT Trust to the Reporting Person on March 26, 2021 without consideration and are now owned directly. Read SEC document |
| March 26, 2021 Filed Mar 30, 2021 22:23 UTC |
Khattar Jack A.Director · President, CEO
|
OtherCommon Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-044088 · tm2111424-1_4seq1.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,466 F1 · price: The Reporting Person is filing this Form 4 to reflect the fact that 10,000 shares were transferred from the KBT Trust to the Reporting Person on March 26, 2021 without consideration and are now owned directly. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 18:46 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantRestricted Stock Units · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-026927 · tm217706-2_4seq1.xml · derivative · entry 3 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,222 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022. F2 · derivative.expiration_date: These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 18:46 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 7,365 | $0.00 Strike: $29.61 | $0.00 |
DisclosureSEC source: 0001104659-21-026927 · tm217706-2_4seq1.xml · derivative · entry 2 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,365 Underlying: Common Stock · 7,365 shares Expires 2031-02-19 Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:54 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $29.61 | $0.00 |
DisclosureSEC source: 0001104659-21-026939 · tm217706-10_4seq1.xml · derivative · entry 1 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-02-19 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 19, 2022. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:53 UTC |
Mottola FrankSVP, Quality, GMP Ops. & IT
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $29.61 | $0.00 |
DisclosureSEC source: 0001104659-21-026935 · tm217706-8_4seq1.xml · derivative · entry 2 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP Ops. & IT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2031-02-19 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 19, 2022. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 18:47 UTC |
Hudson Frederick M.Director
|
GrantRestricted Stock Units · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-026928 · tm217706-3_4seq1.xml · derivative · entry 3 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,222 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022. F2 · derivative.expiration_date: These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 18:47 UTC |
Hudson Frederick M.Director
|
GrantDirector Stock Option (Right to Buy) · Derivative | 7,365 | $0.00 Strike: $29.61 | $0.00 |
DisclosureSEC source: 0001104659-21-026928 · tm217706-3_4seq1.xml · derivative · entry 2 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,365 Underlying: Common Stock · 7,365 shares Expires 2031-02-19 Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 18:49 UTC |
SIEBERT JOHN MDirector
|
GrantRestricted Stock Units · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-026930 · tm217706-5_4seq1.xml · derivative · entry 3 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,222 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022. F2 · derivative.expiration_date: These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 18:49 UTC |
SIEBERT JOHN MDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 7,365 | $0.00 Strike: $29.61 | $0.00 |
DisclosureSEC source: 0001104659-21-026930 · tm217706-5_4seq1.xml · derivative · entry 2 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,365 Underlying: Common Stock · 7,365 shares Expires 2031-02-19 Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:48 UTC |
GEMAYEL GEORGESDirector
|
GrantRestricted Stock Units · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-026929 · tm217706-4_4seq1.xml · derivative · entry 3 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,222 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022. F2 · derivative.expiration_date: These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:48 UTC |
GEMAYEL GEORGESDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 7,365 | $0.00 Strike: $29.61 | $0.00 |
DisclosureSEC source: 0001104659-21-026929 · tm217706-4_4seq1.xml · derivative · entry 2 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,365 Underlying: Common Stock · 7,365 shares Expires 2031-02-19 Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:55 UTC |
Kelly James PatrickExecutive Vice-President & CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $29.61 | $0.00 |
DisclosureSEC source: 0001104659-21-026940 · tm217706d11_4seq1.xml · derivative · entry 1 Kelly James Patrick · CIK 0001506314 · Executive Vice-President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-02-19 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 19, 2022. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:54 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $29.61 | $0.00 |
DisclosureSEC source: 0001104659-21-026937 · tm217706-9_4seq1.xml · derivative · entry 2 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2031-02-19 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 19, 2022. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:51 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $29.61 | $0.00 |
DisclosureSEC source: 0001104659-21-026933 · tm217706-7_4seq1.xml · derivative · entry 1 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2031-02-19 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 19, 2022. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:49 UTC |
Khattar Jack A.Director · President, CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $29.61 | $0.00 |
DisclosureSEC source: 0001104659-21-026931 · tm217706-6_4seq1.xml · derivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-02-19 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 19, 2022. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:46 UTC |
Barlow CarroleeDirector
|
GrantRestricted Stock Units · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-026926 · tm217706-1_4seq1.xml · derivative · entry 3 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,222 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022. F2 · derivative.expiration_date: These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:46 UTC |
Barlow CarroleeDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 7,365 | $0.00 Strike: $29.61 | $0.00 |
DisclosureSEC source: 0001104659-21-026926 · tm217706-1_4seq1.xml · derivative · entry 2 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,365 Underlying: Common Stock · 7,365 shares Expires 2031-02-19 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.